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1. Introduction 
Pulmonary thrombo-embolism (PTE) remains a common cause of morbidity and mortality 
worldwide. Annually, as many as 300,000 people in the United States die from acute 
pulmonary embolism and the diagnosis is often not made until autopsy (Tapson, 2008). 
Obstruction of the pulmonary artery or one of its branches by material other than thrombi is 
commonly referred to as Non-thrombotic Pulmonary Embolism (NTPE). The lungs are a 
prominent target for the embolization of any material larger than approximately 10 microns 
that gains access to the venous circulation. This includes thrombi, air, amniotic fluid, fat, 
injected foreign material, and tumor (Fig 1). In comparison with pulmonary  
thrombo-embolism, NTPE is a less common condition (M. B. King & Harmon, 1994). Its  
complex and diverse etiologies renders it more difficult to accurate diagnosis and  
characterization. Therefore, there is a gross scarcity of epidemiologic data pertaining to this  
group. We speculate that it is often underestimated (both due to under-recognition  
and under-diagnosis). In contrast to pulmonary thrombo-embolism, the complex  
and diverse pathogenesis of different subtypes of emboli is subject to continuing  
speculation and extends beyond “simple’’ mechanical obstruction of pulmonary  
vasculature. Non-thrombotic emboli may also be associated with a severe inflammatory  
response both in the systemic and pulmonary circulation, unlike pulmonary thrombo- 
emboli. 
The diagnosis of NTPE is even more challenging given lack of specific clinical features, 
heterogeneity of radiographic findings as well as lack of specific laboratory blood tests. 
Nonetheless, NTPE can be associated with some specific radiographic findings and 
familiarity with these features should aid in prompt diagnosis (Han et al.,2003). High index 
of clinical suspicion in the appropriate clinical setting often paves the way to prompt 
diagnosis. It is important that the correct type of pulmonary emboli be identified, since 
treatment and prognosis vary considerably. In this chapter, we have summarized the 
current concepts of various types of NTPE. 
2. Fat embolism 
Fat Embolism (FE) is by far the most frequent NTPE observed outside the clinical setting  
of Obstetrics-Gynecology. The term FE refers to the presence of fat globules within the  
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Fig. 1. Different sub-types of NTPE (Reproduced with permission – Jorens et al, ERJ 2009) 
peripheral and pulmonary circulation. It can range from being asymptomatic to life 
threatening respiratory failure with or without neurological and other systemic 
manifestations often described as Fat Embolism Syndrome (FES). 
3. Epidemiology  
The reported incidence of FE & FES varies widely in literature. FE occurs in great majority 
of patients who sustain pelvic or long-bone fractures, endo-medullary nailing of long-
bone fractures or placement of knee and hip prosthesis. Embolic showers of circulating  
fat globules have been demonstrated in up to 41% of patients following surgical nailing of 
long bone fractures (Talbot & Schemitsch, 2006). However, only a small percentage  
of these patients develop FES (406th Medical General Laboratory, Professional Section, 
1951; Deland, 1956; Gossling & Pellegrini, 1982; Gurd & Wilson, 1974; Koessler et al., 2001; 
Levy, 1990; Lozman et al., 1986; Palmovic & McCarroll, 1965; Peltier, 1969; Shier & Wilson, 
1980; Talbot & Schemitsch, 2006). The incidence of posttraumatic FES can range  
from 0.25% (Peltier, 1969) to 35% (Gurd & Wilson, 1974; Lindeque et al., 1987; Riska & 
Myllynen, 1982). The timing of the fracture fixation also appears to impact the incidence 
of FES. Delayed surgery predisposes to a higher incidence. Non-traumatic FE or  
FES is rare. 
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4. Risk factors 
Trauma, orthopedic procedures and soft tissue injuries including severe burns are by far the 
most common causes of FE and FES. FES is more likely to develop after pelvic or lower 
extremity fractures; it is seldom observed in patients with isolated upper extremity 
fractures. 
 
Characteristics Comments 
Age:  10-40 years – peak incidence 
Sex : M > F 
 Physically most active age group – 
higher risk of trauma 
 
 Children <10 yrs old: lower fat and 
olein content of the bone marrow 
(hence, less likely to develop FES) 
 
 Elderly : low impact fractures, 
mostly single fracture, mainly 
involving the neck of the femur 
thus less intramedullary pressure 
and less marrow is available for 
embolization. 
Location of fracture(s) in order of 
incidence: 
 Lower extremity and/or pelvic    
 Upper extremity  
 Rib & vertebrae 
Femur (excluding neck) is the single most   
common site 
Number of fracture(s)
Multiple > single 
More marrow is available for embolization  
Type of fracture
Closed > open 
Higher pressure is more likely to develop in 
closed than open (Dedhia & Mushambi, 
2007; ten Duis et al., 1988; Thomas & Ayyar, 
1972).  
 
Table 1. Traumatic Fat Embolism - Factors predisposing to FES among Trauma patients 
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5. Non-traumatic fat embolism  
Non traumatic Fat embolism or FES is rare and overall incidence is extremely low (Stein et 
al., 2008). It can be divided into three categories. 
 Procedures related (Table-2) 
 Diseases related (Table-3) 
 Drugs related (Table-4) 
6. Non orthopedic procedures associated with fat embolization. (Table-2) 
 
Soft tissue filling  (Coronado-Malagon et al., 2010) 
Bone marrow transplantation  ( Bulger et al., 1997; Hasan et al., 
2001; Jenkins et al., 2002; Lipton et 
al., 1987; Robert et al., 1993)  
Renal transplantation  (Jones et al., 1965; Lipton et al., 
1987) 
Lipectomy  (Laub & Laub, 1990) 
Autologous fat harvesting  (Currie et al., 1997) 
Periurethral injection  (Currie et al., 1997) 
Lymphangiography  (Francis et al., 1983) 
Mineral oil enemas  (Rabah et al., 1987) 
Injection of rice bran oil into breasts  (Kiyokawa et al., 1995) 
Cardiopulmonary resuscitation (Buchanan & Mason, 1982; Bulger 
et al., 1997; Jackson & Greendyke, 
1965; Jenkins et al., 2002; Robert et 
al., 1993)  
Liposuction  Bulger et al., 1997; Guardia et al., 
1989; Jenkins et al., 2002; M. B. King 
& Harmon, 1994;  Laub & Laub, 
1990; Platt et al., 2002; Richards, 
1997; Robert et al., 1993; R. M. Ross 
& Johnson, 1988) 
Intraosseous fluid and drug administration  (Hasan et al., 2001; Vichinsky et al., 
2000) 
Extracorporeal circulation such as extracorporeal 
membrane oxygenation or cardiopulmonary 
bypass  
(Akhtar, 2009; Bulger et al., 1997; 
Gravante et al., 2008; Jenkins et al., 
2002; M. B. King & Harmon, 1994; 
Richards, 1997; Robert et al., 1993; 
ten Duis, 1997)  
Table 2. Procedures related 
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7. Conditions associated with fat embolization (Table-3) 
 
Pancreatitis  (Bulger et al., 1997; Godeau et al., 
1996; Goldhaber, 2004; Guardia et 
al., 1989; Jenkins et al., 2002; M. B. 
King & Harmon, 1994; Lynch, 1954; 
Richards, 1997; Robert et al., 1993) 
Panniculitis  (Goldhaber, 2004) 
Osteomyelitis  ( Broder & Ruzumna, 1967; 
Goldhaber, 2004; M. B. King & 
Harmon, 1994;  Richards, 1997; 
Wagner, 1865)  
Sickle cell crisis  ( Bulger et al., 1997; Goldhaber, 
2004; Hutchinson et al., 1973; 
Jenkins et al., 2002; M. B. King & 
Harmon, 1994; Richards, 1997; 
Robert et al., 1993)  
Alcoholic fatty liver  (Goldhaber, 2004) 
Liquefying subcutaneous hematoma  (Jorens et al., 2009)  
Viral hepatitis in pre-existing fatty liver  (Schulz et al., 1996)  
Bone tumor lysis  (Weinhouse, January 2011) 
Burns  ( Bulger et al., 1997; Jenkins et al., 
2002; M. B. King & Harmon, 1994; 
Levy, 1990; Patil & Wakankar, 2008; 
Richards, 1997; Robert et al., 1993; 
Weisz, 1974) 
Decompression sickness  (Bulger et al., 1997; Haymaker & 
Davison, 1950; Jenkins et al., 2002; 
M. B. King & Harmon, 1994; Ober et 
al., 1959; Richards, 1997; Robert et 
al., 1993)  
Diabetes mellitus  (Cuppage, 1963; M. B. King & 
Harmon, 1994; Richards, 1997; 
Weinhouse, January 2011)   
Table 3. Diseases related 
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8. Drugs associated with fat embolization (Table-4) 
 
Cyclosporine A solvent  (Weinhouse, January 2011)  
Carbon tetrachloride poisoning (Macmahon & Weiss, 1929; 
Taviloglu & Yanar, 2007)  
Infusion of lipids at a rate greater than normal 
clearing capacity, i.e. 3.8 gm/kg/day,  
(Bulger et al., 1997; Haber et al., 
1988; Jenkins et al., 2002; Kitchell & 
Balogh, 1986; Rayburg et al., 2010; 
Ritter et al., 1997; Robert et al., 
1993)  
Intraosseous fluid and drug administration  (Hasan et al., 2001; Vichinsky et al., 
2000)  
Corticosteroids  (Bulger et al., 1997; Jenkins et al., 
2002; Robert et al., 1993; 
Weinhouse, January 2011)   
Table 4. Drugs related 
In view of the large number of patients who are treated with liposome-embedded drugs, 
reports of fatal FE caused by intravenous liposome drug delivery or intra-venous 
hyperalimentation are debatable (Kitchell & Balogh, 1986; Tolentino et al., 2004).  
Pathophysiology of FES remains unknown. Two main theories, namely mechanical and 
biochemical, dominate the literature and have gained acceptance (Bulger et al., 1997; Choi et 
al., 2002; Mellor & Soni, 2001; Parisi et al., 2002).  
9. Mechanical hypothesis 
Gauss first proposed the mechanical theory of fat embolization which requires that large fat 
cells in the bone marrow rupture into the venous circulation through torn venules at the 
fracture site in the setting of a favorable pressure gradient (increased intra-medullary 
pressure). These fat globules subsequently embolize to the lungs and obstruct the 
pulmonary capillaries (Gauss, 1924). Systemic embolization takes place via intra-cardiac 
shunts or PFO. Small fat droplets (7-10 micrometers) can pass through pulmonary 
capillaries (Parisi et al., 2002) causing systemic embolization in the absence of anatomic 
shunt. The clinical picture is dictated by the extent of the organ(s) involved. However, 
mechanical theory does not explain the following observations: 
 Not all patients who have fat emboli develop FES (Aoki et al., 1998)  
 “Latent period”: from the time of onset of injury to the onset of symptoms and signs of 
FES 
 Non-Traumatic causes of FES 
Therefore factors other than mechanical obstruction must be playing a role which led to the 
biochemical hypothesis.  
10. Biochemical hypothesis  
In 1927, Lehman and Moore first postulated that a substance exists that causes 
destabilization of the emulsion of chylomicrons in the bloodstream with coalescence of fat 
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stores in response to stress and catecholamine release (Lehman & Moore, 1927). Currently 
the most widely held view is that there is physiochemical alteration leading to 
degradation of embolized fat and production of toxic intermediates—mainly Free Fatty 
Acids (FFAs). Circulating FFAs originating from triglycerides at the fracture site may 
become concentrated as a result of systemic lipolysis induced by catecholamines. 
Alternatively, fat emboli trapped in pulmonary vessels may be metabolized to FFAs and 
glycerol by lipase secreted by lung parenchymal cells (P. L. Baker et al., 1971). However 
the exact source of FFAs remains unknown. Regardless of the source of the FFAs, 
circulating FFAs level is elevated in patients with fractures and in animal models of 
nontraumatic fat embolism. It has been postulated that decreased hepatic clearance as in 
shock, sepsis, or decreased plasma concentration of albumin also increase the risk of FES ( 
Mays, 1970; Moylan et al., 1976). FFAs have been shown in both animal and human 
studies to have the following systemic effects 
 Toxicity to lung parenchyma:  
  capillary leak 
 curtailed surfactant production 
  interstitial hemorrhage and pulmonary edema (Herndon, 1975; Parker et al., 1974; 
Szabo et al., 1977)  
 Cerebral cortical cell damage (Parisi et al., 2002) 
 Cardiac contractile dysfunction (Dedhia & Mushambi, 2007; Hulman, 1988b)  
 C-reactive protein which is elevated in these patients appears to interact with 
circulating chylomicrons to form fat globules de novo, which can explain non traumatic 
fat embolism (Hulman, 1988a).  
Coagulation cascade activation, disseminated intravascular coagulation (DIC), and 
antifibrinolytic pathways may further contribute to lung injury (E. G. King et al., 1971; 
Saldeen, 1970).The biochemical theory, could explain “latent period” and nontraumatic 
forms of FES (Schnaid et al., 1987). It must be emphasized that evidence is largely 
circumstantial and the exact pathophysiologic mechanism responsible for FES remains 
unknown.  
11. Clinical features 
FES usually presents as multisystem disorder in the setting of long bone fracture(s) or major 
trauma. The most commonly affected organs are brain and lung. The presentation is 
heterogeneous given diverse causes as well as multi-organ involvement. Latent period is 
typically 12 to 72 hours although rarely it can be as short as few hours in the setting of major 
trauma or as long as 2 weeks (Gary, 2004; Johnson & Lucas, 1996; M. B. King & Harmon, 
1994; Mellor & Soni, 2001; Moreau, 1974; Parisi et al., 2002; Peltier, 1984; Schonfeld et al., 
1983; Shier & Wilson, 1980). 85% of patients will develop signs and symptoms within 48 
hours of injury (Sevitt, 1962). The classic triad of hypoxemia, neurological dysfunction and 
petechial rash is seen in only about 50% of the patients.  
12. Pulmonary 
It is uncommon to develop FES in the absence of respiratory manifestations. A great 
majority of patients present with varying degrees of respiratory insufficiency that can range 
from nearly asymptomatic hypoxemia to severe hypoxemia and ARDS requiring mechanical 
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ventilation (Bernard et al., 1994). The most “fulminant” form of FES presents as “acute cor 
pulmonale” with respiratory failure causing death within a matter of few hours, usually 
after a major trauma (Mellor & Soni, 2001; Parisi et al., 2002; Peltier, 1984; Schonfeld et al., 
1983). Although frequently clinically inapparent, hypoxemia is nearly universal (Peltier et 
al., 1974; A. P. Ross, 1970).  
13. Central nervous system 
Neurological findings are nonspecific and usually completely reversible. They can range 
from anxiety and restlessness to comatose state requiring mechanical ventilation. The 
early signs and symptoms are delirium, restlessness, confusion or anxiety. Diffuse 
encephalopathy and coma can ensue (Jacobson et al., 1986). Focal neurological deficits are 
common. These findings are frequently not responsive to correction of hypoxemia 
(Metting et al., 2009) and have infrequently been observed in absence of pulmonary 
involvement.  
14. Skin 
The characteristic petechial rash has been reported to be in present in about 50% to 60% of 
patients with FES. Upper anterior torso, axillae, neck, upper arm, conjunctivae and oral 
mucosa are usual sites. The rash is NOT due to thrombocytopenia but from fat emboli 
obstructing capillaries and causing capillary damage and subsequent hemorrhages. The 
petechial rash may be the only physical sign. 
15. Eye 
Retinopathy has been reported in up to 50% of patients (Adams, 1971). Fundoscopic 
findings (Kearns, 1956) include macular edema, cotton-wool spots, retinal hemorrhages and 
occasional fat droplets. The findings are attributed to microvascular injury  
in the form of microinfarcts of retina which usually disappear with possible residual 
scotomas. 
16. Cardiovascular 
Tachycardia is invariably present. Hemodynamic changes include: (Aebli et al., 2005; Krebs 
et al., 2007; Murphy et al., 1997)  
 Increase in pulmonary arterial pressure due to not only mechanical obstruction from fat 
embolism but also from pulmonary vasoconstriction.  
 Reduction in systemic arterial pressure 
 Reduction in cardiac output 
 Arrythmias 
Cardiovascular deterioration is often transient but can be fulminant resulting in severe 
cardiac failure, cardiac arrest and even death. 
Other findings: Rarely severe hypocalcemia leading to tetany has been reported (Gurd & 
Wilson, 1974). Jaundice/icterus can be present. Hematological findings include anemia, 
thrombocytopenia and DIC (Dines et al., 1972; Herndon, 1975; Hulman, 1988b; McCarthy et 
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al., 1973; Peltier, 1984; Peltier, 1988). Elevation of ESR & CRP, presence of fat globules in the 
urine, sputum or blood, elevation of serum lipase and phospholipase A2 have been 
described. 
17. Role of Bronchial Alveolar Lavage (BAL) 
Presence of lipid inclusions in alveolar macrophages in the BAL has been associated with 
various traumatic and nontraumatic conditions, especially aspiration pneumonia and lipid 
infusion. Quantification of cells containing fat droplets in bronchial alveolar lavage (BAL) 
fluid within the first 24 hours after trauma have also been shown to correlate with clinical 
fat embolism in some studies ) (Al-Khuwaitir et al., 2002; Chastre et al., 1990; Mellor & Soni, 
2001; Mimoz et al., 1995). In the absence of an exogenous source of fat, BAL fluid that 
contains more than 30% macrophages laden with lipid inclusions is highly suggestive of 
FES.  
18. Imaging 
The findings are nonspecific and appear after a variable lag period as related to clinical 
symptoms. Chest roentgenogram may reveal diffuse evenly distributed alveolar and 
interstitial densities suggestive of pulmonary edema or acute lung injury. Computed 
tomography (CT) of the chest may rarely show fat in the pulmonary artery. Multiple sub-
centimeter, ill-defined centrilobular and subpleural nodules can be seen in the acute phase 
of FES. Diffuse lung calcifications located in the branches of the pulmonary arteries have 
been described in the late course of FES (Hamrick-Turner et al., 1994). Ventilation perfusion 
scan (V/Q scan) may reveal subsegmental perfusion defects (H. M. Park et al., 1986).  
Computed tomography (CT) of the brain may show nonspecific signs of cerebral edema and 
hemorrhagic infarcts in multiple areas (Meeke et al., 1987). Magnetic resonance imaging 
(MRI) of the brain and MR spectroscopy seem to be the most sensitive method in detection 
of cerebral emboli, but nonspecific  (J. J. Chen et al., 2008; Eguia et al., 2007; Guillevin et al., 
2005; Sasano et al., 2004; Satoh et al., 1997; Stoeger et al., 1998). Diffusion-weighted imaging 
may reveal bright spots on a dark background, a finding known as the ‘‘Starfield pattern’’ 
(Parizel et al., 2001). Cerebral micro-emboli can be detected in vivo after long bone fracture 
by transcranial Doppler (Barak et al., 2008; Forteza et al., 1999).  
Transesophageal Echo (TEE) is most useful for diagnosing intra-operative FES. TEE has 
sensitivity of 80% and specificity of 100% in patients with fat embolism large enough to 
cause hemodynamic instability (Pruszczyk et al., 1997). TEE cannot reliably distinguish fat 
emboli from tumor emboli.  
19. Diagnosis   
Given the extremely heterogeneous pattern of presentation, precise diagnosis of FES 
remains elusive. Various diagnostic criteria have been proposed. However given the lack of 
gold standard diagnostic tests and lack of pathognomic signs, it is difficult to determine 
validity of these criteria. Therefore the diagnosis of FES is based on a constellation of clinical 
and laboratory findings and exclusion of other potential diagnoses (Taviloglu & Yanar, 
2007).  
The following diagnostic criteria are widely used. 
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Major Minor 
 
 Respiratory insufficiency 
 Cerebral involvement 
 Petechial rash 
 Pyrexia 
 Tachycardia 
 Retinal changes 
 Jaundice 
 Renal changes (anuria or oliguria) 
 Thrombocytopenia (a drop of >50% 
                of the admission platelet count) 
 High erythrocyte sedimentation 
rate 
 Fat macroglobulinemia 
 
Table 5. Gurd and Wilson:  FES = 1 major + 4 minor + Fat microglobulinemia 
 
Criterion Points 
Diffuse petechiae 5 
Alveolar infiltrates 4 
Hypoxemia  <70 mm Hg 3 
Confusion 1 
Fever 38 C 1 
Heart rate >120/min 1 
Respiratory rate >30/min 1 
Table 6. Schonfeld’s criteria - FES = 5 or more points 
20. Management 
There is no definitive therapy for FES. The treatment is mainly supportive. Maintenance of 
adequate oxygenation, ensuring hemodynamic stability, prophylaxis of venous thrombosis 
and stress related gastrointestinal bleeding and nutrition are key aspects. Therefore clinical 
management strategies should be geared towards prophylactic measures in trauma victims. 
Early stabilization of the fractures as well as early operative intervention reduces the 
incidence and severity of FES (Al-Khuwaitir et al., 2002; A. B. Baker, 1976; Bone et al., 1989; 
Jenkins et al., 2002; Johnson & Lucas, 1996; Parisi et al., 2002; Riska et al., 1976; Riska & 
Myllynen, 1982; Svenningsen et al., 1987; Tachakra et al., 1990; Talucci et al., 1983). Early ( < 
24 hours) fixation of the fracture of the femur was associated with an improved outcome 
even in patients with concomitant head and chest trauma (Brundage et al., 2002). When 
fracture stabilization was delayed in patients with multiple injuries, the incidence of ARDS, 
FE and pneumonia, the costs of hospital care and the number of days in the intensive care 
unit (ICU) were increased (Behrman et al., 1990; Bone et al., 1989). Intraosseous pressure 
limitation during orthopedic procedures reduces the intravasation of intramedullary fat and 
other debris and therefore may reduce the incidence and severity of FES (Y. H. Kim et al., 
2002; Kropfl et al., 1999; Pitto et al., 1999; Pitto et al., 2002; Pitto, Schramm et al., 1999).  
Incidence and severity of FES are decreased when corticosteroids are given prophylactically, 
although no mortality benefit has been demonstrated (Alho et al., 1978; Bederman et al., 
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2009; Kallenbach et al., 1987; Lindeque et al., 1987; Schonfeld et al., 1983). Nonetheless, 
prophylactic use of corticosteroids remains controversial mainly because of lack of large 
scale studies. The results of treatment with drugs, including clofibrate, dextran-40, ethyl 
alcohol, heparin, and aspirin are inconclusive  (K. M. Chan et al., 1984; Gossling & 
Pellegrini, 1982; Peltier, 1984; Shier et al., 1977; Stoltenberg & Gustilo, 1979).  
21. Prognosis 
With timely supportive care and hemodynamic support, most patients with FES recover 
completely. Mortality rate has been variably reported to be 10 to 20% (Fabian et al., 1990; 
Moreau, 1974; Peltier, 1965; Peltier et al., 1974).  
22. Septic pulmonary embolism 
Septic pulmonary embolism (SPE) is an uncommon but serious disorder that is often 
difficult to diagnose. SPE are thrombi containing microorganisms in a fibrin matrix that are 
mobilized via the bloodstream from an infectious nidus to get implanted into the vascular 
system of the lungs. The organisms can be bacteria, fungi or parasites.  
23. Epidemiology 
In 1978, MacMillan et al. (MacMillan et al., 1978) studied 60 patients with SPE over a 5-year 
period and reported that most of SPE cases occurred in drug users. Intravenous drug abuse 
(IVDA-78%) and tricuspid endocarditis were identified as the embolic source in 53% of these 
IVDA cases (fig 2b) (MacMillan et al., 1978). However, the epidemiology and outcome of 
patients with SPE have changed over the past 30 years with the increased use of long term 
indwelling catheters and devices (pacemakers, prosthetic vascular devices) and also increase 
in the number of immune-compromised patients. The predominant cause of SPE in the 
current era is infections related to intravascular devices/catheters or soft-tissue infections. 
Its incidence is declining among IVDA presumably due to greater needle hygiene (Fig 2a) 
(Cook et al., 2005). Intravascular devices are a common cause of local site infection and 
cause up to 50% of the nosocomial bacteremias. Central venous catheters account for 80-90% 
of these infections.  
In a large series of postmortem examinations in Japan, a total of 11,367 PE cases were 
identified from 396,982 postmortem examinations. In this study, the incidence of septic PE 
was found to be 2.2% (Sakuma et al., 2007).  
24. Risk factors 
A prerequisite for the development of SPE appears to be a heavily infected source such as 
long-term indwelling vascular devices, bacterial endocarditis of the right heart valves or 
peripheral thrombophlebitis (head and neck or pelvic infections) leading to showers of septic 
emboli to the lung. In the above-mentioned recent Japanese study with 247 SPE patients, 
fungal emboli were more common than bacterial emboli. Among the fungi, Aspergillus was 
the most common pathogen (20.8%) encountered preceding Mucor or Candida. Cancer was 
the most common predisposing factor associated with fungal SPE (63%) – Leukemia (43.2%), 
followed by adenocarcinoma and lymphoma. The top three infectious sources showering 
septic emboli were pneumonia, sepsis and infective endocarditis. 
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Fig. 2. (a & b): Causes of Septic Pulmonary Embolism  
(Cook et al., 2005; MacMillan et al., 1978)  
25. Pathophysiology 
Septic emboli are transported to the lung via the hematogenous route from various sources 
of infection. These emboli cause occlusion of the small, peripheral pulmonary arteries 
leading to pulmonary infarction which could further complicate to microabscesses. 
Extravasation from the bronchial arteries – “pulmonary hemorrhages”, may cause 
peripheral consolidation. (Fig 3- Flow chart).  
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A peculiar subtype is Lemierre’s syndrome (postanginal sepsis), a severe illness caused by 
the anaerobic bacterium, Fusobacterium necrophorum which typically occurs in healthy 
teenagers and young adults. The infection originates in the throat as tonsillo-pharyngitis, 
odontogenic infection, mastoiditis or sinusitis and spreads via a septic thrombophlebitis of 
the tonsillar vein and internal jugular vein. The ensuing bacteremia is complicated by septic 
emboli to a range of sites such as lung, joints, and bones. Pulmonary involvement in 
Lemierre’s syndrome has been reported in up to 97% with SPE, lung abscesses and 
empyema (Golpe et al., 1999; Riordan & Wilson, 2004; Sinave et al., 1989). The causative 
organisms of Lemierre’s syndrome include the anaerobic gram-negative Fusobacterium 
species, and also Eikenella, Porphyromonas, Streptococci and Bacteroides. Recently, 
methicillin-resistant Staphylococcus aureus has been identified as a new causative agent 
(Riordan & Wilson, 2004).  
 
 
Fig. 3. 
26. Clinical features 
The clinical features of SPE are non-specific and patients generally present with a febrile 
illness, cough, hemoptysis, dyspnea and pleuritic chest pain. Diffuse cavitary lung nodules 
and infiltrates associated with an active focus of extra-pulmonary infection should clue the 
www.intechopen.com
 Pulmonary Embolism 
 
88
clinician into thinking about a diagnosis of SPE. Other pulmonary complications of SPE 
include pleural effusion, empyema, and rupture of subpleural lesions leading to 
spontaneous pneumothorax. 
 
 
Fig. 4. Clinical manifestations of SPE 
Lemierre’s syndrome usually occurs in previously healthy adolescent or young adults, 
generally presenting with high grade fever (39-41˚C) and rigors. History is usually 
significant for sore throat, tooth ache, odynophagia, dysphagia and chest pain in the week 
preceding the presentation. On examination the patient appears ill, may have signs of 
periodontal disease, the tonsils are usually inflamed with exudates and peritonsillar 
abscesses releasing foul-smelling pus. ‘‘The diagnosis of this infection may be suggested by 
the peculiar odour—like Limburger or overripe Camembert cheese—of pus produced by 
it.’’(Alston, 1955). Signs of internal jugular vein thrombosis may be present in 26–45% of 
cases. Features suggestive of the development of internal jugular vein thrombophlebitis 
include neck pain and stiffness, cervical lymphadenopathy often in the anterior triangle and 
more characteristically a tender (normally unilateral) swelling at the angle of the jaw- 
anterior to, and parallel with, the sternomastoid muscle (Riordan & Wilson, 2004).  
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27. Diagnosis 
Clinical and radiological features at presentation are usually nonspecific and the diagnosis is 
frequently delayed (Huang et al., 1989). Radiographic findings, predisposing background or 
illness, and clinical evidence of infection usually are clues to the diagnosis. Blood cultures, 
chest CT and echocardiography are valuable when evaluating a patient with suspected SPE. 
Basic laboratory testing provides some clues to diagnosis. Patients typically have a 
neutrophil predominant leucocytosis. Liver function tests are abnormal in approximately 
50% of patients. C-reactive protein is invariably raised. 
Microbiology: The diagnosis of bacteremia or fungemia is confirmed by recovery of the 
same species of micro-organisms from the peripheral blood cultures and from quantitative 
cultures obtained from the source of SPE. Pus drained from any site should be sent for 
culture, including catheter tip, localized abscesses in the neck, empyema, septic arthritis, 
bone, and soft tissue abscesses. 
Chest radiograph findings are usually nonspecific with a spectrum of radiological 
abnormalities. The usual findings include patchy air space opacities simulating nonspecific 
broncho-pneumonia, multiple ill-defined nodules (usually 1-3 cm) in various stages of 
cavitation with irregular thick walls or wedge-shaped densities of varying sizes located 
peripherally abutting the pleura. Other x-ray features also include blunting of the 
costophrenic angle, indicating small pleural effusions or empyema.  
Computed tomography (CT) of the chest: Common findings are patchy consolidation with 
air bronchograms, nodules in various stages of cavitation (predominant in the lower lobes), 
wedge-shaped peripheral lesions abutting the pleura with or without extension into the 
pleural space - pleural effusion/empyema, and hilar or mediastinal lymphadenopathy. The 
“feeding vessel sign” has been considered highly suggestive (although not pathognomonic) of 
septic PE and consists of a distinct vessel leading directly into the center of a nodule (Fig 5). 
This sign may represent hematogenous spread to the lungs and may also be seen in 
metastasis. The prevalence of this sign varies from 67–100% in various series and the 
heterogeneous sub pleural wedge-shaped opacities are seen in 70–75% of patients (Kwon et 
al., 2007). Multi-detector CT is faster and superior to the classical CT technology for 
detection of this sign (Dodd et al., 2006).  
 
 
Fig. 5. The “Feeding vessel” sign and multiple peripheral cavitating lesions suggestive of 
SPE 
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Features Gram Positive SPE Gram negative SPE 
1) Size of emboli Larger Smaller 
2) Radiographic 
Characteristics   
1) Cavitation 
2) Air 
bronchograms in 
nodules 
3) Peripheral 
wedge shaped 
opacities 
1) ‘Halo sign’: Central 
area of soft tissue 
attenuation 
surrounded by a 
halo of ground-
glass attenuation. 
2) Hemorrhagic 
nodules and infarcts 
3) “Feeding vessel” 
sign 
Table 7. Characteristics of SPE 
Echocardiography is an important tool in evaluating patients for endocarditis. Trans-
esophageal echocardiography (TEE) increases the sensitivity of detecting vegetations from 
75 to 95 percent while maintaining the specificity of 85 to 98 percent and is thus, superior to 
the transthoracic technique (TTE) in delineating vegetations, abscesses and leaflet 
perforations in the heart (Dodd et al., 2006).  
28. Treatment 
Recent studies demonstrate improved outcomes for patients with SPE with virtually all 
patients recovering from their illness. This may be attributable to earlier diagnosis, prompt 
administration of broad-spectrum antibiotics and improvements in surgical and supportive 
care. Discontinuation of vascular catheters/devices is recommended. In Lemierre’s 
syndrome, vigorous antibiotic treatment for 4-6 weeks, targeting the organism and drainage 
of accessible abscesses are indicated. Internal jugular vein ligation/excision is rarely 
indicated as is the use of anticoagulation (Armstrong et al., 2000; Lustig et al., 1995). 
Consensus recommendation(American Heart Association (AHA), British Society for 
Antimicrobial Chemotherapy (BSAC), and the European Society for Cardiology (ESC)) is 
that, prompt use of antibiotics in treatment of endocarditis may result in reduction of 
incidence of SPE (Baddour et al., 2005; Elliott et al., 2004). The recommended duration of 
antibiotics is 4 to 6 weeks. The 2008 American College of Chest Physicians (ACCP) 
guidelines recommend against the use of routine antithrombotic therapy unless a separate 
indication exists. 
29. Amniotic fluid embolism 
AFE is an exceedingly rare and one of the most catastrophic complications of pregnancy. It 
remains an enigma to this date, more than half a century after the first published autopsy 
series. AFE is responsible for significant proportion of maternal mortality (Lang & King, 
2008; Lewis, 2007). The presence of fetal debris in the pulmonary circulation of a mother 
who died suddenly during labor was first reported by Meyer in 1926 (Meyer, 1926) and 
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subsequently by Steiner and Lushbaugh in 1941 as an autopsy series (Steiner & Lushbaugh, 
1941).  
30. Epidemiology & risk factors 
The true incidence of AFE remains unknown and is variably reported in literature. The 
incidence of AFE has been estimated to be in 1 in 8000 to 80000 deliveries with reported 
mortality rates in older reports as high as 60%. However, more recent data suggest lower 
mortality rates ranging between 27-37% (Clark et al., 1995; Morgan, 1979; Tuffnell, 2005). For 
unknown reasons, the incidence of AFE is much higher in North America, around 1 in 15000 
deliveries, Australia -1 in 30000 deliveries (C. L. Roberts et al., 2010), United Kingdom – 1 in 
50000 (Abenhaim et al., 2008; Knight et al., 2010; Kramer et al., 2006).  
AFE usually occurs during immediate postpartum period. Data from a national registry 
revealed that AFE occurred during labor but before delivery in 70% of cases and during 
caesarean section in 19% (Clark et al., 1995). Although, reported as early as second trimester, 
the diagnosis in cases occurring as late as 36 h postpartum has been described (Devriendt et 
al., 1995). AFE following trans-abdominal amniocentesis is very rare (Hasaart & Essed, 
1983). It has been estimated that AFE accounted for 12% of all maternal deaths related to 
legally induced abortion since 1972 (Grimes & Schulz, 1985; Guidotti et al., 1981). It is 
seldom associated with (surgical) manipulation during caesarean section (Laforga, 1997), 
curettage (Grimes & Cates, 1977), cervical suture removal (Margan et al., 1984) or repair of 
an incompetent cervix (Margan et al., 1984), or after car or motor vehicle accidents (Olcott et 
al., 1973). Large fetal size, use of oxytocics and vaginal prostaglandins, advanced gestational 
age, amnio-infusion or complicated labor have all been implicated (Maher et al., 1994; 
Morgan, 1979). In reality, specific risk factors have not been conclusively identified. Logistic 
regression identified advanced maternal age, placental pathologies and caesarean deliveries 
in a large population-based cohort study (Abenhaim et al., 2008). Maternal age below 20 
years and dystocia has been associated with lower incidence of AFE.  
Pathophysiology: The pathogenesis of AFE remains poorly understood. The detection of 
fetal tissue in maternal pulmonary artery is not pathognomonic. In fact, there is no clear 
temporal relationship between entry of amniotic fluid in to maternal circulation and 
symptom onset. The “antigenic” nature of AF along with pulmonary eosinophilic infiltrates, 
elevated antitryptase activity suggestive of mast cell degranulation has resulted in some 
authors to propose “Anaphylactoid syndrome of Pregnancy” as an alternative name to AFE. 
Autopsy findings frequently reveal disseminated intravascular coagulation (DIC). Isolated 
DIC may herald AFE. Amniotic fluid accelerates clot initiation and propagation. 
Hemodynamic Effects:  A biphasic pattern of hemodynamic changes have been favored in 
most recent descriptions. The “acute phase” comprising of acute elevation of pulmonary 
arterial pressure (“acute Cor Pulmonale”), followed by left ventricular dysfunction/failure.  
31. Clinical features 
AFE is a diagnosis of exclusion. It typically occurs during labor and delivery or in the 
immediate postpartum period, although it can occur as late as 48 hours postpartum. About 
70% of cases occur before delivery (range, 63–76%). The symptoms are often sudden and 
protean. AFE is typified by maternal collapse associated with breathlessness, cyanosis, 
cardiac dysrhythymia, hypotension and then haemorrhage associated with DIC. Clark et al,  
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Adjusted odds ratio (95% confidence interval) 
Characteristics Kramer et al ( Canadian 
Cohort) (Kramer et al., 
2006) 
Abenhaim et al ( 
American Cohort) 
(Abenhaim et al., 2008) 
Maternal age 35 years 1.9 (1. –2.7) 2.2 (1.5–2. ) 
Cesarean delivery 12.5 (7.9 –19.9) - cephalic 
presentation 
8.6 (4.3–17.4) – non-
cephalic presentation 
5.7 (3.7–8.7) 
Forcep  delivery 5.9 (3.4–10.3) 4.3 (1.9–6.6) 
Vacuum delivery 2.9 (1.6–5.3) 1.9 (1  –3.7) 
Abr ptio placen a --- 8.0 (4.0–15.9) 
Placenta previa ---- 30.4 (15.4–60.1) 
Abruptio placenta or 
placenta previa 
3.5 (2.3–5.5)  
Eclampsia 11.5 (2.8–46.9) 29.1 (7.1–119.3) 
Fetal distress 1.7 (1.2–2.5) 1.5 (1.0–2.2) 
 
Table 8. Risk factors associated with an increased risk of AFE in two large registries. 
found the most common presenting signs and symptoms were hypotension and signs of 
non-reassuring fetal status (100%), pulmonary edema or respiratory symptoms (93%), 
cardiac arrest (87%), cyanosis (83%), and coagulopathy (83%). A majority develop seizures, 
encephalopathy and permanent neurological sequelae [85], due to cerebral ischemia and 
anoxia. The clinical course seems to have phases that are likely temporally related to 
pathophysiologic changes (Clark, 1990). 
 
Induced abortion (Grimes & Schulz, 1985; Guidotti et al., 
1981; Lawson et al., 1990) 
foeticide (Edwards & Davies, 2000; Shojai et al., 2003) 
Intrapartum amnioinfusion (Dorairajan & Soundararaghavan, 2005; 
Maher et al., 1994) 
Transabdominal amniocentesis (Hasaart & Essed, 1983; Paterson et al., 
1977)  
Blunt abdominal trauma (Judich et al., 1998; Olcott et al., 1973) 
Surgical trauma (Pluymakers et al., 2007)  
Removal of cervical sutures (Haines & Wilkes, 2003; Margan et al., 1984) 
Manual removal of placenta (Manchanda & Sriemevan, 2005) 
Table 9. Procedures associated with AFE. 
32. Diagnosis 
The diagnosis of AFE is “clinical” and one of exclusion. AFE should be suspected if a 
woman experiences one or more of the following during late pregnancy or within 48 hours 
of delivery: acute or sudden onset of hypotension and/or cardiac arrest, hypoxemia, 
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seizures or coma, DIC and in absence of potential alternative explanation for these 
manifestations (Table 2). Demonstration of fetal squamous cells in pulmonary arterial 
circulation is not pathognomonic. Presence of AF cells in BAL may be supportive. There are 
no specific laboratory tests for diagnosing AFE. Diagnostic markers for AFE have been 
developed which rely on detection of fetal or amniotic fluid constituents in maternal 
circulation, such as Serum Sialyl Tn Antigen, (Benson et al., 2001; Kobayashi et al., 1993; Oi 
et al., 1998) and plasma zinc coproporphyrin (a component of meconium) (Kanayama et al., 
1992). Serum Tryptase, a marker of mast cell degranulation may be elevated but unreliable 
(Dorne et al., 2002; Farrar & Gherman, 2001; Marcus et al., 2005; Nishio et al., 2002).  
33. Management 
There is no specific treatment for AFE. The condition can be neither predicted nor 
prevented. The principles of management of AFE are mainly supportive, ie, to restore and 
maintain hemodynamic stability, to correct hypoxia and maintain adequate oxygenation, 
correction of coagulopathy with blood products as necessary and to deliver the fetus 
promptly at the earliest sign of maternal or fetal distress. Given sudden or hyperacute 
manner of presentation, prompt and aggressive response from the treating clinician is a 
must. As the diagnosis is not always clear from the onset of collapse, the role of diagnostic 
tests is to exclude conditions that can be treated specifically such as, Thrombotic PE which is 
more common compared to AFE. Hypoxia must be corrected promptly as significant 
proportions of survivors have residual neurological impairment due to cerebral anoxia 
(Moore & Baldisseri, 2005). Hypotension and shock should be aggressively treated with 
intravenous fluids, vasopressors and ionotropes as necessary. Since clinical manifestations 
are biphasic and complex, invasive hemodynamic monitoring is essential. Additional data 
from trans-thoracic or trans-esophageal echocardiography may be useful (James et al., 2004; 
Koegler et al., 1994; Stanten et al., 2003; van Haeften et al., 1989; Verroust et al., 2007). 
Administration of blood component is considered the first line treatment for coagulopathy 
associated with AFE. DIC is frequently associated with severe hemorrhage, so transfusion of 
packed red blood cells is a priority to maintain adequate tissue oxygenation. Uterine atony 
with DIC is a dangerous complication that might require immediate surgical intervention 
such as, hysterectomy.  
As AFE occurred during labor in a predominant number of cases, immediate delivery of 
fetus by means of caesarian section is mandatory to prevent fetal hypoxic damage and to 
facilitate resuscitation (Davies & Harrison, 1992; Prasad & Howell, September 2001). 
Advanced cardiac life support (ACLS) protocol should be followed in case of cardiac arrest. 
The goal of drug therapy is to restore normal maternal hemodynamics in conjunction with 
the delivery of the fetus as soon as possible after the onset of asystole or malignant 
arrhythmia. During resuscitation, the uterus should be displaced to the left to avoid 
compression of the large vessels and improve venous return.  
34. Prognosis 
AFE accounts for approximately 10% of all maternal death within the USA (Atrash et al., 
1990). Case fatality rate has declined significantly in recent years due to the prompt and 
aggressive resuscitation measures. (Abenhaim et al., 2008; Benson, 1993; Clark et al., 1995; 
Morgan, 1979). There is higher likelihood of survival if the women survive long enough to 
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be transferred to intensive care unit. AFE still carries significant morbidity which includes 
neurological deficit in significant proportions of mothers as well as newborn. Neonatal 
survival is reported to be at 70%.  
 
Either In the absence of any other clear cause 
Acute maternal collapse with one or more of the following features: 
    Acute fetal compromise 
    Cardiac arrhythmias or arrest 
    Coagulopathy 
    Convulsion 
    Hypotension 
    Maternal haemorrhage 
    Premonitory symptoms, e.g. restlessness, numbness, agitation, tingling 
    Shortness of breath 
Excluding women with maternal haemorrhage as the first presenting 
feature in whom there was no evidence of early coagulopathy or 
cardiorespiratory compromise 
 
Or Women in whom the diagnosis was made at post-mortem examination by 
finding fetal squames or hair in the lungs 
Table 10. UK Obstetric Surveillance System (UKOSS) criteria for defining cases of AFE 
35. Tumor embolism 
Pulmonary tumor emboli are defined as clumps of malignant cells within the lumina of 
pulmonary arteries and arterioles (Kane et al., 1975). Microscopic pulmonary tumor emboli 
involve the small pulmonary arteries, arterioles and alveolar septal capillaries which are 
occluded by aggregates of tumor cells accompanied by platelet-fibrin thrombosis.  
Types:  
1. “Acute” tumor emboli - “massive” tumor emboli that can result in symptoms over 
“days” 
2. “Sub-acute” tumor emboli - multiple small emboli resulting in “symptoms” over weeks 
to months 
36. History & epidemiology 
In 1897, Schmidt (M. B. Schmidt, 1903) first described pulmonary tumor embolization in a 
patient with gastric carcinoma. Autopsy showed the pulmonary bed was massively 
occluded by tumor emboli and pathology was similar to gastric tumor cells. It was not 
until 1937 that Brill and Robertson (Brill & Robertson, 1937) described the clinical 
syndrome of sub acute cor-pulmonale due to multiple tumor emboli to the pulmonary 
microvasculature. This syndrome is rare and exceedingly difficult to recognize before 
death. Since then pulmonary tumor embolism has been described in a variety of 
malignancies. 
The estimated incidence of pulmonary tumor embolism is 3-26% among patients with solid 
tumors as reported by autopsy series (Bast et al., 2000; Kane et al., 1975; Shields & Edwards, 
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1992). Despite the relative prevalence at autopsy, the diagnosis is infrequently made ante 
mortem and thus the incidence of clinically significant tumor embolism is unclear (C. K. 
Chan et al., 1987). Retrospective chart reviews demonstrate that only 8% of patients with 
pathological evidence of tumor emboli have documented morbidity and mortality (Kane et 
al., 1975; Shields & Edwards, 1992).  
37. Etiology 
The risk appears to be greatest with mucin secreting adenocarcinomas of the breast, lung, 
stomach and colon. However, PTE has also been reported in hepatocellular, prostate, renal 
cell and choriocarcinomas. Other rare associations are listed below (K. E. Roberts et al., 
2003). 
 
Breast                                                     
Stomach               
Lung                
Liver           
Prostate               
Pancreas           
Bone           
Undifferentiated carcinoma         
Ovary                
Bladder          
Cervix           
Colorectal          
Kidney           
Mesothelioma          
Wilms’ tumor  
Esophageal 
Parotid  
Melanoma 
Myxoma 
Thyroid  
Trophoblastic 
Vulva 
Neurogenic sarcoma 
38. Pathology 
Histological studies of tumor emboli in humans and animals have provided some insights 
into the fate of pulmonary tumor emboli. Schimdt noted that tumor emboli are usually 
associated with intravascular platelet-fibrin rich thrombi. As a result, cancer cells become 
fewer and degenerative in appearance during the organization of these thrombi. The 
tumor emboli have no tendency to invade the arterial wall (Winterbauer et al., 1968). 
Necropsy studies and animal model studies suggest that tumor emboli are destroyed or 
remain latent and are not truly metastases. Soares et al (Soares et al., 1993) studied 222 
consecutive autopsies of cancer cases and detected pulmonary hypertensive arteriopathy 
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with proliferative endarteritis. Thus, PTE may be pathologically indistinguishable from 
other forms of pulmonary arterial hypertension, except for the notable absence of 
plexiform lesions. Some investigators describe tumor emboli as possessing an unusual 
level of resistance to recannulation (as compared to thromboembolism) and therefore 
likely lead to progressive and irreversible obstruction of the pulmonary vascular bed 
(Winterbauer et al., 1968).  
Pathophysiology: Pulmonary vasculature provides the first capillary bed to the circulating 
tumor cells. The process of pulmonary metastasis consists of sequential steps that includes 
intravascular and/or lymphatic invasion of the lung by the neoplastic cells. Large scale 
autopsy studies suggest that tumor cells spread to the pulmonary vasculature in basically 4 
ways (Kane et al., 1975; Winterbauer et al., 1968):  
1. Large tumor emboli to the main pulmonary artery or large lobar branches producing 
the syndrome of acute pulmonary hypertension. 
2. Microscopic tumor embolization involving small arteries and arterioles accounting for 
progressive dyspnea and subacute pulmonary hypertension. 
3. Generalized lymphatic dissemination leading to pulmonary microvascular involvement 
(lymphatic carcinomatosis) causing diffuse interstitial infiltrates. 
4. A combination of the above three mechanisms. 
Clinical features: In most patients, primary malignancy was established when tumor emboli 
were noted. The signs and symptoms are non-specific. Patients with large proximal emboli 
have rapid onset of symptoms due to acute right heart failure indistinguishable from the 
presentation of a massive thromboembolism. Lymphangitic carcinomatosis and 
microvascular disease involving small pulmonary arteries, follow a more deliberate and 
progressive course resulting in subacute cor pulmonale. 
Physical examination shows evidence of pulmonary hypertension and signs of right heart 
dysfunction. Common findings included: tachypnea, tachycardia, cyanosis, hypotension, 
elevated Jugular venous distension (JVD), audible pulmonic sound (P2), ascites and 
peripheral edema. Although considered “classic”, signs of right heart failure are only 
reported in 15% to 20% of patients with this syndrome (Veinot et al., 1992).  
Diagnosis: Ante-mortem diagnosis of pulmonary tumor embolism can be very difficult due 
to lack of distinctive features compared to thrombo-embolism which is more common. 
Diagnosis often made via tissue specimens from open lung biopsy or autopsy. Pulmonary 
arterial sampling (in a wedge position) has resulted in diagnosis in a few cases (Masson & 
Ruggieri, 1985; K. E. Roberts et al., 2003).  
39. Management 
Treatment of the pulmonary tumor embolism is directed at the primary tumor. Complete 
surgical resection of the primary tumor results in gradual resolution of the tumor emboli 
and reversal of the respiratory symptoms in patients with renal cell carcinoma,  
atrial myxoma and choriocarcinoma (C. K. Chan et al., 1987). The curative surgical 
resection in these cases may be due to early recognition or related to the less aggressive 
nature of the underlying malignancies. Embolectomy and IVC filter placement have been 
employed in the rare patients suffering from large, central pulmonary tumor emboli 
arising from infra-diaphramatic tumors. Chemotherapy generally does not affect the 
prognosis unless the primary tumor is very chemo-sensitive i.e. Wilm’s tumor or 
trophoblastic tumors.  
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40. Pulmonary cement embolism 
Pulmonary Cement Embolism (PCE) is a complication of Percutaneous Vertebroplasy (PVP) 
and Balloon Kyphoplasty which are minimally invasive procedures used to treat 
osteoporotic and other vertebral fractures (Galibert et al., 1987; Garfin et al., 2001;Gigante & 
Pierangeli, 2008; McDonald et al., 2008; Oner et al., 2006; Stoffel et al., 2007; Wu & Fourney, 
2005). Polymethylmethacrylate (PMMA, “cement” ) leakage is a frequent occurrence during 
these procedures and the source of PCE (Gangi et al., 1999; Garfin et al., 2001; Hauck et al., 
2005; Hodler et al., 2003; R. Schmidt et al., 2005; Vasconcelos et al., 2002; Yeom et al., 2003). 
The risk of pulmonary cement embolism (PCE) ranges from 3.5% to 23% for osteoporotic 
fractures (Anselmetti et al., 2005; Choe et al., 2004; Duran et al., 2007; Y. J. Kim et al., 2009). A 
recent report suggested a prevalence of 8.8% (Gill et al., 2010). Exact incidence is difficult to 
estimate as many are asymptomatic and escape detection. Patients with malignant lesions of 
the vertebrae might be at a higher risk of developing PCE due to damaged cortical substance 
and increased vascularity, while technical factors such as inappropriate viscosity of the 
cement at the time of injection, lack of visual guidance and higher cement volume injected 
during the procedure increase the risk of PCE (Baroud et al., 2006; Bohner et al., 2003; Choe 
et al., 2004; Deramond et al., 1998).The clinical spectrum following PMMA leakage is broad:  
asymptomatic extravasation into surrounding tissues, features of nerve root compression 
(Kelekis et al., 2003; Laredo & Hamze, 2005; Ratliff et al., 2001), asymptomatic and 
symptomatic pulmonary cement embolism (Anselmetti et al., 2005; Choe et al., 2004; Duran 
et al., 2007; Y. J. Kim et al., 2009), even cardiac perforation (S. Y. Kim et al., 2005; Lim et al., 
2008; Schoenes et al., 2008; Son et al., 2008) and death (H. L. Chen et al., 2002; Monticelli et 
al., 2005; Stricker et al., 2004; Yoo et al., 2004) have been reported. Fat embolism occurring 
simultaneously with cement embolism may also contribute to the clinical picture (Aebli et 
al., 2002; Rauschmann et al., 2004). Clinically PCE cannot be distinguished from thrombotic 
pulmonary embolism (Bernhard et al., 2003; Jang et al., 2002; Padovani et al., 1999; Tozzi et 
al., 2002). Diagnosis is based on history and imaging which shows presence of radio-opaque 
densities (Figs 6 a&b). There is not enough evidence to underlay treatment guidelines. Since 
cement is regarded as “thrombogenic”, (Francois et al., 2003; Perrin et al., 1999; Righini et al., 
2006; Tozzi et al., 2002) anticoagulation for 6 months is recommended for symptomatic 
patients or patients with central PCE. Asymptomatic patients with peripheral PCE should 
have close clinical follow up with no anticoagulation. Surgical embolectomy may be 
considered for exceptional cases of central embolism. Routine chest roentogenogram should 
be obtained after  PVP and BKP regardless of the symptoms as many patients are 
asymptomatic.  
41. Gas embolism 
Gas embolism (GE) is mainly ambient “air” embolism (AE) but also includes other gases 
such as carbon dioxide, nitrous oxide, nitrogen and helium. It is a rare and potentially fatal 
condition. There are 2 main types of GE, i.e, venous and arterial. They are distinguished by 
the mechanism of entry. Venous GE (VGE) occurs usually as a complication of iatrogenic 
procedures such as vascular catheter placement, mechanical ventilation and rarely surgical 
procedures (pulmonary lung biopsy, open heart surgeries, craniotomy). Arterial GE causes 
ischemia. As little as 0.5ml of air can result in coronary ischemia, cardiac arrhythmias, 
serious brain damage and even death.  
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Fig. 6. a: Chest radiograph showing radio-opaque density in right main pulmonary artery 
 
 
Fig. 6. b: CT Chest revealing bright intravascular densities in segmental and subsegmental 
pulmonary arteries 
In venous GE, manifestations include cough, dyspnea, tachypnea and a hypoxemic ‘‘gasp’’ 
reflex when 10% or more of the pulmonary vessels are occluded (Souders, 2000; Sviri et al., 
2004). Arterial embolization into the coronary arteries induces a specific drum-like or ‘‘mill-
wheel’’ murmur along with electrocardiographic changes of ischemia (Rossi et al., 2000). 
The key to controlling air embolism lies in prevention. First line of treatment includes 
administration of 100% oxygen, placing the patient in left lateral decubitus position  
to prevent right ventricular outflow obstruction by airlock. Hyperbaric Oxygen (HBO) may be 
used. 100% oxygen decreases the size of the gas bubbles by increasing the ambient pressure 
and by establishing a diffusion gradient that favors the elimination of gas  
from the bubbles and by increasing the gradient for the egress of nitrogen from  
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the bubbles (Muth & Shank, 2000; Van Liew et al., 1993). Adjunctive treatment, includes fluid 
administration and  prophylaxis against venous thromboembolism in paralyzed patients. 
Treatment is effective in most cases, although residual deficits can remain in serious cases. 
42. Foreign body embolism 
42.1 Silicone embolism 
Silicone is thought to be an immunological inert substance and a component of many 
implantable medical devices. Silicone emboli (SIE) were first reported in trans-sexual males in 
1970’s and then later in young healthy women seeking low cost enhancements. Silicone 
implants are approved and widely used for breast augmentation, however liquid silicone used 
for aesthetic purposes cause significant morbidity when injected in the hips and buttocks, face, 
breasts, and vagina and is illegal in the US (Bartsich & Wu, 2010). Clinical features are similar 
to fat embolism with majority of patients meeting Schonfeld criteria (Schmid et al., 2005). The 
most common presentation is hypoxemia (92%) (Bartsich & Wu, 2010). Silicone embolic 
syndrome (SES) is a constellation of mainly pulmonary symptoms including dyspnea, fever, 
cough, hemoptysis, chest pain, hypoxia, alveolar hemorrhage, and altered consciousness 
presenting in patients shortly after silicone injection (within the first few hours) (Schmid et al., 
2005). Later sequelae may occur within a few days and the possibility of delayed-onset 
pneumonitis or local inflammation at injection sites can occur up to years after administration 
(Chastre et al., 1987). Several factors have been implicated in leading to silicone emboli, 
including large volume injections, high-pressure infiltration, particle migration, and 
intravascular injection (Villa & Sparacio, 2000). It is thought that alveolar macrophages ingest 
silicone and fat to provoke an inflammatory response by increasing vascular permeability, 
activating endothelial cells, inducing the accumulation of activated neutrophils and 
modulating immunoregulatory responses in the lung. Imaging is usually suggestive of an 
embolic, congestive, pneumonitis or diffuse alveolar damage pattern. Treatment is supportive, 
consisting mainly of supplemental oxygen and steroid therapy. 
43. Hyaluronic acid embolism  
Hyaluronic acid (HA) is an approved dermal filler used for correction of facial wrinkles and 
folds (H. J. Park et al., 2010). All other uses are considered off label and illegal. HA associated 
pulmonary emboli (HAAPE) have been described in few case reports (Famularo et al., 2001; 
H.J. Park et al., 2010). Typical presentation of HAAPE is acute respiratory failure within hours 
after the HA injection in the anterior wall of the vagina, G-Spot amplification or for lip 
amplification by an unlicensed medical practitioner. Due to the extensive venous plexus, 
procedures involving injections in and around the injection site can cause NTPE. Although HA 
is thought to be non-immunogenic, it can cause localized granulomatous foreign body 
reactions with multinucleated giant cells around amorphous basophilic materials in the 
pulmonary vessels and lung parenchyma, as seen on video-assisted lung biopsy (Fernandez-
Acenero et al., 2003; Honig et al., 2003; Raulin et al., 2000). Treatment is mainly supportive. 
44. Others 
Any material that is injected intravenously can potentially enter the pulmonary circulation 
leading to pulmonary embolism. Foreign materials such as talc, starch, cotton, and cellulose 
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used as insoluble binding agents in oral tablets, are first pulverized, then dissolved in water 
and injected by intravenous drug users, and may be carried by the bloodstream until they 
lodge in the pulmonary capillary bed to cause NTPE (Farber et al., 1989; Ferrer et al., 2002; 
Low & Nicol, 2006; Pare et al., 1989).  
The advent of modern percutaneous interventional procedures has led to a rise in catheter 
or fragment related pulmonary embolism. Catheter embolism usually takes place when the 
catheter is withdrawn from the introducing needle causing the distal portion of the catheter 
be sheared off (Propp et al., 1988). Spontaneous catheter breakage accounts for 25% of the 
catheter emboli. Retained catheter fragments have high rate of complications such as 
arrhythmias, perforations and thrombus formation (Fisher & Ferreyro, 1978; Richardson et 
al., 1974).  
Prostate brachytherapy can also lead to embolization of radioactive seeds. On imaging the 
radioactive seeds appear as small (Iodine-125 measures 4.8 mm in length and 0.8 mm in 
diameter) metallic densities, usually detected incidentally. Clinical implications of these 
embolized radioactive seed implants remain unclear. Patients with arteriovenous 
malformations undergo therapeutic cerebral embolization with different materials such as 
cyano-acrylate agents, polyvinyl alcohol foam particles, micro-coils, silk or dacron thread 
and balloons. Cyano-acrylate has been reported to cause symptomatic pulmonary embolism 
(Kjellin et al., 2000; Pelz et al., 1995). Intravenous injection of elemental mercury is rare and 
has typically been reported in relation to psychiatric or suicidal incidents (Givica-Perez et 
al., 2001). Systemic embolization of mercury has been reported as well (Shareeff et al., 2000; 
Vas et al., 1980). On imaging, multiple metallic densities are seen. Mercury may remain in 
the body for a long time and metallic densities may remain visible for years after the 
injection (Ambre et al., 1977).  
45. Conclusion 
NTPE continues to pose a diagnostic challenge in clinical medicine despite much advancement 
in laboratory testing and imaging. Improved awareness along with techniques to allow for 
more accurate ante-mortem diagnosis may faciltitate early and prompt recognition of these 
syndromes which may in turn pave the way for better treatment modalities.  
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